Medicine
RYANODEX dantrolene sodium 1000 mg/20 mL injectable suspension
RYANODEX dantrolene sodium 1000 mg/20 mL injectable suspension is a prescription medicine containing Dantrolene for intravenous use, marketed by Eagle Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store unreconstituted product at 20 °C to 25 °C (68 ºF to 77 ºF), with…
Key facts
- Active ingredient (INN)
- Dantrolene
- Brand
- RYANODEX dantrolene sodium
- Strength
- 1000 mg/20 mL
- Dosage form
- Injectable suspension
- Route
- Intravenous
- Packs
- 1 vial of 20 mL
- Marketing authorisation holder
- Eagle Pharmaceuticals
- Manufacturer
- Eagle Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store unreconstituted product at 20 °C to 25 °C (68 ºF to 77 ºF), with excursions permitted to 15 ºC to 30 ºC (59 ºF to 86 ºF) and avoid prolonged exposure to light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03CA01 Dantrolene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 July 2014
- Identifiers
- RxCUI 1544753, 1544758DailyMed set ID 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698NDC 42367-540Application NDA205579
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 20 mL in 1 vial | 42367-540-32 | Eagle Pharmaceuticals | 23 July 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dantrolene
Clinical summary
Dantrolene is a skeletal muscle relaxant indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis), among other approved uses. MedsAcross supplies Dantrolene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DantroleneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dantrium prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
- Agilus: European public assessment report (EPAR) · European Medicines Agency
Need RYANODEX dantrolene sodium 1000 mg/20 mL injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.